Nitrendipine

尼群地平

Report date: 2023/03/03 20:00:36
NME

Base Information

Drug NameNitrendipine
Drug Alias NameBaypressBaylotensinBayotensinBay-e-5009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionAngina Pectoris
Global Approved IndicationsHypertensionAngina Pectoris
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEUMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe PharmaHeilongjiang Hasing Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC08CA08
Related LinksWikipediaDrugBankKEGG